Learn More
Medchemexpress LLC Atezolizumab-MMAE (antibody-drug conjugate) | 98.0% | 500 UG

Supplier: Medchemexpress LLC HY171572500UG
Atezolizumab-MMAE is an antibody-drug conjugate composed of the anti-PD-L1 monoclonal antibody atezolizumab covalently linked to the cytotoxic payload monomethyl auristatin E (MMAE). Supplied as a liquid formulation for research use, the certificate of analysis reports concentration, formulation, purity, and storage conditions.
- Antibody-drug conjugate targeting PD-L1.
- Concentration 3.77 mg/mL in 10 mM histidine, pH 5.5.
- Purity 98.0% by SEC-HPLC.
- Appearance colorless to light yellow (liquid).
- Store at -80°C and protect from light.
- For research use only; not for human therapeutic use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.